Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A family-based weight loss randomized controlled trial for youth with intellectual disabilities.
A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease Continuum.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Herb use, vitamin use, and diet in low-income, postpartum women.
Using Multiphoton Intravital Microscopy to Study Neutrophil Transmigration and Blood-Brain Barrier Permeability in a Mouse Model of Herpes Simplex Virus Encephalitis.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Cachia D, Izzy S, Berriosmorales I, Ionete C. Drug-induced thrombocytopenia secondary to natalizumab treatment. BMJ Case Rep. 2014 May 30; 2014.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Anti-Inflammatory Agents
Diagnosis, Differential
Female
Humans
Methylprednisolone
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Natalizumab
Prednisone
Rituximab
Thrombocytopenia
authors with profiles
Carolina Ionete MD, PhD
David M Cachia MD
Idanis M Berrios Morales MD